Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? . Clinics. 2011;66(7):1171-1175. doi:10.1590/S1807-59322011000700008